Published in Women's Health Weekly, January 4th, 1999
The encouraging results with this combination, says drug manufacturer Rhone-Poulenc Rorer, have prompted the launch of a U.S. clinical trial comparing it with a standard chemotherapy regimen in patients with early stage breast cancer. The researchers hope that this new regimen will increase the likelihood of curing early stage disease.
"This trial demonstrated that Taxotere and doxorubicin is an active...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.